Blood-based miRNA Diagnostic Model for Multi-cancer Detection
An innovation enabled with deep expertise in bioinformatics on cancer research
The first-ever miRNA-based multi-cancer detection model
miRNA is widely recognized as a promising biomarker for disease diagnostics. miRoncol developed the first miRNA-based multi-cancer detection model.
Unmatched accuracy from the industry
At 99.9% specificity, sensitivity showed consistently high across 12 cancers with x range from xxx - to xxx.
12 types of cancer that have a significant impact if detected earlier
Initial validation on a large dataset
Our invention has been validated on a large public dataset with over 7000 blood samples providing a strong statistical significance.
miRNA or microRNA - Nobel-wining
miRNA as diagnostics biomarker for cancer
Related to Gene expression
miRNA is stable and can be handled by existing facilities. No special or expensive equipment required
MCED is proven market - NIH, Grail
From extraction, to analysis, to xxx, end of end handling can levarage existing infrastructure.
Based on circulating miRNA, it only requires a blood draw. Therefore, it is non-invasive.
miRNA extraction and test can be done at any lab with an RT-PCR machine which is widely available.